15th INTERNATIONAL CONGRESS OF PARKINSON'S
15th INTERNATIONAL CONGRESS OF PARKINSON'S
15th INTERNATIONAL CONGRESS OF PARKINSON'S
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Guided Poster Tours<br />
Guided Poster Tour 9 – Surgical therapy of<br />
movement disorders other than Parkinson’s disease<br />
South Building, Level 800, Room 808<br />
13:30 - 15:00<br />
Wednesday, June 8, 2011<br />
Tour Leaders: Joachim Krauss, Hannover, Germany<br />
Elena Moro, Toronto, ON, Canada<br />
261 Stepwise implantation of multiple electrodes in the globus pallidus<br />
internus in the treatment of primary generalized dystonia<br />
L. Cif, V. Gonzalez, X. Vasques, A. Corlobé, A.M. Moura, A. Bonafé,<br />
P. Coubes (Montpellier, France)<br />
287 Low frequency deep brain stimulation for dystonia: Lower is not<br />
always better<br />
F.M. Velez, K.D. Foote, G. Oyama, N. Hwynn, P. Zeilman, C. Jacobson,<br />
M.S. Okun (Gainesville, Florida, USA)<br />
288 Predictive factors of outcome in primary cervical dystonia treated<br />
with bilateral pallidal deep brain stimulation (DBS)<br />
J.L. Witt, R. Ash, E. Moro, P.A. Starr, A.M. Lozano, M. Hodaie, Y.-<br />
Y. Poon, C. Hamani, J.L. Ostrem (San Francisco, California, USA)<br />
275 Shorter disease duration associated with improved long-term<br />
outcome after GPi DBS in young-onset DYT1+ primary torsion<br />
dystonia (PTD) patients<br />
L.C. Markun, P.A. Starr, M.M. Volz, J.L. Ostrem (San Francisco,<br />
California, USA)<br />
278 Bilateral pallidal deep-brain stimulation in dystonia syndromes:<br />
Long-term outcome and safety<br />
L.M. Romito, G. Zorzi, M. Ciceri, A. Franzini, N. Nardocci,<br />
A. Albanese (Milano, Italy)<br />
290 Mild hypokinetic gait changes induced by bilateral pallidal deep<br />
brain stimulation for segmental dystonia<br />
M.E. Wolf, C. Blahak, H.H. Capelle, M.G. Hennerici, J.K. Krauss<br />
(Mannheim, Germany)<br />
262 Loss of benefit from VIM thalamic deep brain stimulation (DBS) for<br />
essential tremor (ET): A single center review of long-term outcomes<br />
K. Czarnecki, C. Lim, E. Papavassiliou, D. Tarsy, L.C. Shih (Boston,<br />
Massachusetts, USA)<br />
258 The relationship between thalamic local field potentials, scalp EEG<br />
and EMG during tics in Gilles de la Tourette syndrome<br />
L.J. Bour, L. Ackermans, E.M. Foncke, C. van der Linden, D. Cath,<br />
V. Visser-Vandewalle, M.A. de Koning-Tijssen (Amsterdam,<br />
Netherlands)<br />
280 Pallidal surgery for dystonia in Wilson’s disease<br />
C.S. Sankhla, M. Chhabria, M. Sankhe, V. Udani, A. Ravan (Mumbai,<br />
India)<br />
291 Surgical treatment for neuroacanthocytosis<br />
F. Yokochi, K. Kimura, R. Okiyama, M. Taniguchi, M. Yokochi (Tokyo,<br />
Japan)<br />
15 th <strong>INTERNATIONAL</strong> <strong>CONGRESS</strong> <strong>OF</strong> PARKINSON’S<br />
DISEASE AND MOVEMENT DISORDERS<br />
Guided Poster Tour 10 – Genetics<br />
South Building, Level 800, Room 808<br />
13:30 - 15:00<br />
Wednesday, June 8, 2011<br />
Tour Leaders: Andrea Nemeth, Oxford, United Kingdom<br />
Oksana Suchowersky, Calgary, AB, Canada<br />
931 A novel PARK2 mutation in a Peruvian family: Clinical and<br />
pathological characteristics<br />
L. Torres, M.R. Cornejo, I. Mata, P.E. Mazzetti, C. Cosentino, D. Rivas,<br />
C.P. Zabetian, J.B. Leverenz (Seattle, Washington, USA)<br />
920 Interaction of NAT2 and UCHL1 genotypes influences the risk and<br />
age at onset of Parkinson’s disease<br />
A. Gobel, E.A. Macklin, S. Winkler, K. Lohmann, C. Klein,<br />
D.K. Simon (Luebeck, Germany)<br />
928 Frequency of the mutations in the PARK2, PINK1 and DJ-1 genes in<br />
Polish patients with the early-onset form of Parkinson’s disease<br />
D. Koziorowski, D. Hoffman-Zacharska, J. Slawek, P. Górka, J. Bal,<br />
A. Roszmann, A. Friedman (Warsaw, Poland)<br />
927 Young onset parkinsonism due to alpha synuclein gene<br />
multiplication in a consanguineous family – A case report<br />
M. Kojovic, U.M. Sheerin, N. Wood, H. Houlden, J. Hardy, K.P. Bhatia<br />
(London, United Kingdom)<br />
926 Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism<br />
in Greek patients with Parkinson’s disease. Association with clinical<br />
parameters of the disease<br />
C. Karakasis, K. Kalinderi, Z. Katsarou, L. Fidani, S. Bostantzopoulou<br />
(Thessaloniki, Greece)<br />
930 Role of serotonin receptor 2A gene variants in the impulsive<br />
compulsive behaviors (ICB) in Parkinson’s disease (PD)<br />
J.-Y. Lee, B.S. Jeon, H.-J. Kim, J.-Y. Kim, S.-S. Park (Seoul, Republic of<br />
Korea)<br />
925 The LRRK2 G2019S mutation predisposes Parkinson’s disease<br />
patients to cancer<br />
R. Inzelberg, O. Cohen, J. Aharon-Peretz, I. Schlesinger, R. Gershoni-<br />
Baruch, R. Djaldetti, Z. Nitsan, L. Ephraty, O. Tunkel, E. Kozlova,<br />
L. Inzelberg, N. Kaplan, E. Schechtman, E. Friedman, S. Hassin-Baer<br />
(Tel Hashomer, Israel)<br />
960 Rapid-onset dystonia-parkinsonism: Searching for a new gene<br />
K. Zschiedrich, A. Weissbach, S. Winkler, K. Isbruch, M. Schwarz,<br />
C. Klein, K. Lohmann (Lübeck, Germany)<br />
945 Clinical and genetic spectrum of myoclonus dystonia syndrome<br />
K.J. Peall, A.J. Waite, M.A. Kurian, T. Hedderly, M. Smith, J.-<br />
P. Lin, M.D. King, T.T. Warner, H. Pall, P. Chinnery, A. Whone,<br />
K.K. Mantripragada, N.M. Williams, M.J. Owen, D.J. Blake,<br />
H.R. Morris (Cardiff, United Kingdom)<br />
912 The Cuban program for SCA2 predictive diagnosis: A 1,000 patients<br />
review<br />
T. Cruz Mariño, Y. González Zaldivar, M. Velázquez Santos,<br />
A. Estupiñán Quesada, R. Aguilera Rodríguez, Y. Vázquez Mojena,<br />
R. Reynaldo Armiñán, J.M. Laffita Mesa, L.E. Almaguer Mederos,<br />
M. Paneque Herrera, L. Velázquez Pérez (Holguín, Cuba)<br />
TORONTO<br />
81<br />
June 5–9, 2011 Toronto, ON, C anada<br />
Guided<br />
Poster Tours
Change language